Literature DB >> 7629664

Anterior transposition of the inferior oblique in the treatment of unilateral superior oblique palsy.

C González1, G Cinciripini.   

Abstract

Anterior transposition of the inferior oblique (ATIO), is an accepted surgical procedure for the treatment of primary inferior oblique overaction and dissociated vertical deviation. Our study was undertaken to see if ATIO could be useful in the treatment of preselected unilateral superior oblique palsy (SOP) patients. Three consecutive patients with unilateral SOP with preoperative primary-position hypertropia averaging 27 delta, Knapp class V, underwent ATIO. The results were excellent and none of these patients developed primary-position hypotropia. Complications of ATIO in our patients consisted of some elevation deficiency, elevation of the lower lid in upgaze, and reduced inferior "scleral show" in the surgically treated eye. We are proposing that ATIO be considered as a beneficial operation in unilateral SOP patients with at least 25 delta of preoperative primary-position hypertropia.

Entities:  

Mesh:

Year:  1995        PMID: 7629664     DOI: 10.3928/0191-3913-19950301-11

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  3 in total

1.  The neurofibrovascular bundle of the inferior oblique muscle as its ancillary origin.

Authors:  D R Stager
Journal:  Trans Am Ophthalmol Soc       Date:  1996

2.  Traumatic tear of the inferior rectus muscle treated with inferior oblique anterior transposition.

Authors:  Katyanne Dantas Godeiro; Anderson Gustavo Teixeira Pinto; Joao Pessoa Souza Filho; Ana Maria Noriega Petrilli; Celia Regina Nakanami
Journal:  Int Ophthalmol       Date:  2007-02-08       Impact factor: 2.031

3.  The effect of anterior transposition of the inferior oblique muscle on eyelid configuration and function.

Authors:  Tugba Goncu; Sevim Cakmak; Ali Akal; Halit Oguz
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.